Yoga-Based Group Intervention for Inpatients with Schizophrenia Spectrum Disorders—Feasibility, Acceptability, and Preliminary Outcomes of a Rater-Blinded Randomized Controlled Trial.
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 66 of the 67 references it cites were found in a registry or an index; 32 of the 68 sources its claims cite were checked for support.
Abstract
Background and Hypothesis The efficacy of yoga as an adjunctive treatment for schizophrenia spectrum disorders (SSD) has garnered interest. While yoga may positively influence various symptom domains, further investigation is needed due to the limited number, quality, and generalizability of studies. This study assessed the feasibility and acceptability (primary outcome) of a yoga-based group intervention (YoGI) developed in a participatory approach and explored its preliminary effectiveness. Study Design In addition to the primary outcomes, this preregistered randomized controlled trial examined rater-blinded general psychopathology, positive- and negative symptoms, and self-rated depression, anxiety, stress, body mindfulness, mindfulness, psychological flexibility, cognition, social functioning, quality of life, and medication regime at baseline and postintervention as secondary outcomes. Study Results Fifty inpatients with SSD received either TAU (n = 25) or YoGI + TAU (n = 25) for four weeks. Outcomes showed 95% protocol adherence of YoGI, feasibility, and retention rates of 91% and 94%, respectively, and a dropout rate of 6%. ANCOVA revealed significant between-group postintervention improvements for YoGI + TAU in positive symptoms, depression, cognitive fusion, and a mindfulness subscale. Medium-to-large pre- to postintervention effects were found for body mindfulness, positive, negative, and general psychopathology, cognitive fusion, depression, anxiety, stress, quality of life, and attention in YoGI + TAU, while within-group changes were consistently smaller in TAU. No severe adverse events were reported. Conclusions This trial supports the feasibility and acceptability of YoGI for inpatients with SSD and provides preliminary evidence of YoGI's benefits beyond TAU. Further robust, multicentric RCTs are warranted to deepen our understanding of YoGI's therapeutic potential and inform clinical interventions for SSD.
Overview
CoChat Summary
TL;DR
This rater-blinded RCT assessed feasibility, acceptability, and preliminary outcomes of a participatory yoga-based group intervention (YoGI) added to treatment as usual (TAU) in 50 inpatients with schizophrenia spectrum disorders. YoGI was feasible and acceptable and showed preliminary benefits beyond TAU on several symptom and mindfulness measures, but the small monocentric inpatient sample limits conclusions.
Key findings
- Feasibility/acceptability: YoGI protocol adherence was 95%, feasibility and retention rates were 91% and 94%, and dropout was 6% (n = 3/50); n = 5 of N = 55 eligible patients were unwilling to participate. No severe adverse events were reported; 81% of individual YoGI sessions had no adverse events, with somatic events most common (n = 15; mean severity M = 1.29, SD = 0.75, mild-to-moderate).
- Between-group ANCOVA at postintervention favored YoGI + TAU for positive symptoms (PANSS Positive: F = 5.93, p = .02, η²p = 0.11), depression (DASS Depression: F = 4.36, p = .04, η²p = 0.08), cognitive fusion (CFQ: F = 10.71, p = .00, η²p = 0.19), and the Southampton Mindfulness Questionnaire Letting Go subscale (F = 6.25, p = .04, η²p = 0.08).
- Within YoGI + TAU, medium-to-large pre- to postintervention effects were reported for body mindfulness, positive, negative, and general psychopathology, cognitive fusion, depression, anxiety, stress, quality of life, and attention; within-group changes were consistently smaller in TAU.
- Negative symptoms improved in both groups (mean reduction 2.8 points for YoGI + TAU and 2.4 points for TAU), exceeding the cited minimum clinically significant difference of 1.5 points.
Methods
- Monocentric, preregistered (NCT04730518), rater-blinded RCT with parallel groups; inpatients with ICD-10 F2-spectrum diagnoses at Charité–Universitätsmedizin Berlin were randomized 1:1 to TAU (n = 25) or YoGI + TAU (n = 25). Recruitment ran January 2021–September 2023; assessments were at baseline and 4 weeks postintervention, with adverse events assessed weekly after YoGI sessions.
- YoGI consisted of four weekly 1-hour Hatha yoga-oriented group sessions (breathing exercises, body awareness, asanas, final relaxation, brief verbal exchanges), delivered in an open group format of up to eight participants, in addition to guideline-based TAU.
- Analyses used descriptive feasibility thresholds (stop <70%, adapt >70%–<90%, go >90%), ANCOVA with baseline scores as covariates and partial eta-squared, paired-sample t-tests with Cohen’s d, α = .05 two-tailed, no alpha correction due to exploratory nature, and simple mean imputation for three dropouts’ missing postintervention data.
Limitations
- Stated: the monocentric design and specific inpatient setting limit generalizability; self-reported evaluations may be affected by reporter-sided biases such as social desirability; the study occurred during the COVID-19 pandemic and may have time-specific transferability issues; no follow-up time points were included; the small sample size can inflate effect sizes; and as a feasibility study it was not primarily aimed at large-scale clinical implications.
- Stated: future multicentric RCTs with larger and more diverse samples, including outpatients, are needed to detect true effects and enhance generalizability.
- Evident from the text: many secondary outcomes were tested without alpha correction for multiple testing, increasing the risk that some significant exploratory findings are chance findings; the three dropouts’ missing data were handled by simple mean imputation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
28 Valid · 2 Not valid · 22 Not checked · 107 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“yoga-based group intervention (YoGI) was explicitly developed for persons with SSD using a participatory approach together with a total of n = 44 participants.30,31”
What the sources say
- Partly supportedcites [30] 30. Schulze T, Hahn E, Hahne I, et al. Yoga-based group intervention for in-patients with schizophrenia spectrum disorders – a qualitative approach. Front Psychiatry. 2021;12:715670. https://doi.org/ 10.3389/fpsyt.2021.715670 [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Introduction describes YoGI as a newly developed intervention for in-patients with schizophrenia spectrum disorders. But the Methods report 25 interviewees, not 44 participants, and the Discussion says the YoGI protocol was developed with psychologists and trained yoga teachers; our copy does not establish that 44 patients participated in its development. (LLM, conf=0.86)
- Partly supportedcites [31] 31. Töbelmann LC, Hahne I, Schulze T, et al. Mechanisms of action and processes of yoga-based group intervention for inpatients with schizophrenia spectrum disorders – a longitudinal qualitative study. Front Psychiatry. 2023;14:81. https://doi.org/ 10.3389/fpsyt.2023.1086468 [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
Section 2.5 (Yoga-based group intervention; page unavailable) says YoGI was tailored to patients with SSD and its manual was developed in collaboration with patients, supporting the participatory-development claim. It does not say that 44 people participated in that development; the Abstract (Material and methods; page unavailable) instead reports 33 participants in this study, 19 of whom received YoGI. (LLM, conf=0.88)
plainn = 44- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Targeting negative symptoms in SSD has been particularly challenging, as they do not respond well to available pharmacological treatments.60”
What the sources say
- Partly supportedcites [60] 60. Correll CU, Schooler NR. Negative symptoms in Schizophrenia: a review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat. 2020;16:519–534. https://doi.org/ 10.2147/NDT.S225643 [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Results > Treatment section says most available drugs have limited effects on negative symptoms of schizophrenia, supporting the stated treatment challenge. The claim extends that conclusion to schizophrenia spectrum disorders more broadly, which the cited passages do not establish. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“A total sample size of N = 50 participants was determined conservatively, reflecting recommendations of n = 12-28 participants per study arm in pilot trials.46,47”
What the sources say
- Could not verifycites [46] 46. Jacobsen P, Hodkinson K, Peters E, Chadwick P. A systematic scoping review of psychological therapies for psychosis within acute psychiatric in-patient settings. Br J Psychiatry. 2018;213:490–497. https://doi.org/ 10.1192/bjp.2018.106 [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Results section (Review Question 2; page unavailable) reports that 10 of 19 published RCTs had fewer than 25 people in the treatment arm. It does not give a recommended pilot-trial sample size of 12–28 per arm or explain a decision to recruit 50 participants. Searches for those numbers and for pilot-trial sample-size recommendations found no supporting passage. (LLM, conf=0.74)
- Not checked — no full text of the sourcecites [47] 47. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10:307–312. https://doi.org/ 10.1111/j..2002.384.doc.x [DOI] [PubMed] [Google Scholar] source
plainn = 50- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“consistent medium effects on the reduction of negative symptoms in both short- (Hedges’s g = 0.44) and long-term (Hedges’s g = 0.35).”
What the sources say
- Partly supportedcites [27] 27. Vancampfort D, Vansteelandt K, Scheewe T, et al. Yoga in schizophrenia: a systematic review of randomised controlled trials. Acta Psychiatr Scand. 2012;126:12–20. https://doi.org/ 10.1111/j.1600-0447.2012.01865.x [DOI] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The ‘Effectiveness of yoga on positive and negative symptoms’ section (page not provided) reports reductions in negative symptoms in the reviewed trials. It does not report the claimed Hedges’s g values or establish consistent medium effects at both short- and long-term follow-up. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Disembodiment processes permeate throughout all facets of schizophrenia psychopathology, eg, abnormal bodily experiences, a diminished innate consciousness of one’s own body as a cohesive entity, and disorganized thought and speech.57,58”
What the sources say
- Not checked — no full text of the sourcecites [57] 57. Park S, Baxter T. Schizophrenia in the flesh: revisiting schizophrenia as a disorder of the bodily self. Schizophr Res. 2022;242:113–117. https://doi.org/ 10.1016/j.schres.2021.12.031 [DOI] [PubMed] [Google Scholar] source
- Supportedcites [58] 58. Tonna M, Lucarini V, Borrelli DF, Parmigiani S, Marchesi C. Disembodiment and language in schizophrenia: an integrated psychopathological and evolutionary perspective. Schizophr Bull. 2023;49:161–171. https://doi.org/ 10.1093/schbul/sbac146 [DOI] [PMC free article] [PubMed] [Google Scholar] source
The Discussion states that disruption of embodiment processes reverberates in all dimensions of schizophrenia psychopathology. It explicitly lists abnormal bodily experiences, diminished awareness of the body as a unified entity, and thought and speech disorganization as examples. Page numbers are unavailable in our copy. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
74 more claims · 4 with their cited sources checked
Create a free account to see all 159 claims and to verify the 2 references still open.
- It may state two separate claims as one. 55
- Probably not a substantial claim. 36
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“PANSS Total −20.46; −8.90 −5.24 .00 *** −14.70 −1.05 −1.64; −0.46 −11.19; 1.75 −1.51 .15 −4.72 −0.30 −0.86; 0.26”
Reported -4.72 · recomputed -8.4
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Methods
“rated on a 3-point Likert Scale”
§ Methods
“0—not at all, 1—mild, 2—moderate, 3—severe”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“CDS Total −5.25; −1.50 −3.72 .00 *** −3.38 −0.76 −1.33; −0.19 −4.25; −1.45 −3.45 .00 ** −2.65 −0.72 −1.29; 0.15”
Reported -2.65 · recomputed -2.85
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results
“WHO-QoL Social Relationships 0.86 (1,47) .36 0.18”
§ Results
“0.00; 0,12”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Nonjudgement −0.58; 1.58 1.43 .20 1.00 0.27 −0.29; 0.83”
Reported 1 · recomputed 0.5
3 more findings
Create a free account to see every finding of this check.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686
Eta squared and partial eta squared as measures of effect size in educational research
Richardson, J. T. E. (2011) · Educational Research Review · doi:10.1016/j.edurev.2010.12.001 · Cited by 3,465
Design and analysis of pilot studies: recommendations for good practice
Lancaster, G. A., Dodd, S., & Williamson, P. R. (2004) · Journal of Evaluation in Clinical Practice · doi:10.1111/j..2002.384.doc.x · Cited by 2,572
Analysing controlled trials with baseline and follow up measurements
Vickers, A. J., & Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7321.1123 · Cited by 2,116
Huhn, M., Nikolakopoulou, A., Schneider-Thoma, J., Krause, M., Samara, M., Peter, N., Arndt, T., Bäckers, L., Rothe, P., Cipriani, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31135-3 · Cited by 1,753
(2008) · Australian journal of advanced nursing · Cited by 1,687
Correll, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225643 · Cited by 911
The development and initial validation of the cognitive fusion questionnaire
Gillanders, D. T., Bolderston, H., Bond, F. W., Dempster, M., Flaxman, P. E., Campbell, L., Kerr, S., Tansey, L., Noel, P., Ferenbach, C., et al. (2014) · Behavior Therapy · doi:10.1016/j.beth.2013.09.001 · Cited by 837
Definition and description of schizophrenia in the DSM-5
Tandon, R., Gaebel, W., Barch, D. M., Bustillo, J., Gur, R. E., Heckers, S., Malaspina, D., Owen, M. J., Schultz, S., Tsuang, M., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.028 · Cited by 807
Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
Leucht, S., Samara, M., Heres, S., & Davis, J. M. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv167 · Cited by 762
Reliability and validity of a depression rating scale for schizophrenics
Addington, D., Addington, J., Maticka-Tyndale, E., & Joyce, J. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90003-n · Cited by 651
Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia
Peralta, V., & Cuesta, M. J. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90093-0 · Cited by 583
Avery, K. N. L., Williamson, P. R., Gamble, C., O'Connell Francischetto, E., Metcalfe, C., Davidson, P., Williams, H., & Blazeby, J. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013537 · Cited by 575
Moreno-Küstner, B., Martín, C., & Pastor, L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195687 · Cited by 562
Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Samara, M., Rabaioli, M., Bächer, S., Cipriani, A., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16121358 · Cited by 542
Chadwick, P., Hember, M., Symes, J., Peters, E., Kuipers, E., & Dagnan, D. (2008) · British Journal of Clinical Psychology · doi:10.1348/014466508x314891 · Cited by 517
Jauhar, S., McKenna, P. J., Radua, J., Fung, E., Salvador, R., & Laws, K. R. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.116285 · Cited by 517
Hayasaka, Y., Purgato, M., Magni, L. R., Ogawa, Y., Takeshima, N., Cipriani, A., Barbui, C., Leucht, S., & Furukawa, T. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.021 · Cited by 401
Dauwan, M., Begemann, M. J. H., Heringa, S. M., & Sommer, I. E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv164 · Cited by 393
Zimmermann, G., Favrod, J., Trieu, V. H., & Pomini, V. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.018 · Cited by 371
Breath of Life: The Respiratory Vagal Stimulation Model of Contemplative Activity
Gerritsen, R. J. S., & Band, G. P. H. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00397 · Cited by 342
Psychometric properties of the Depression Anxiety Stress Scales (DASS) in depressed clinical samples
Page, A. C., Hooke, G. R., & Morrison, D. L. (2007) · British Journal of Clinical Psychology · doi:10.1348/014466506x158996 · Cited by 301
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Haddad, P. M., & Correll, C. U. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318781475 · Cited by 259
Nasrallah, H., Morosini, P., & Gagnon, D. D. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.012 · Cited by 243
Stip, E., Caron, J., Renaud, S., Pampoulova, T., & Lecomte, Y. (2003) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(03)00086-5 · Cited by 214
Jakubovski, E., Varigonda, A. L., Freemantle, N., Taylor, M. J., & Bloch, M. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030331 · Cited by 197
Management of psychosis and schizophrenia in adults: summary of updated NICE guidance
Kuipers, E., Yesufu-Udechuku, A., Taylor, C., & Kendall, T. (2014) · BMJ · doi:10.1136/bmj.g1173 · Cited by 194
Solmi, M., Croatto, G., Piva, G., Rosson, S., Fusar-Poli, P., Rubio, J. M., Carvalho, A. F., Vieta, E., Arango, C., DeTore, N. R., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01727-z · Cited by 147
Jansen, J. E., Gleeson, J., Bendall, S., Rice, S., & Alvarez-Jimenez, M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.016 · Cited by 144
Vancampfort, D., De Hert, M., Knapen, J., Wampers, M., Demunter, H., Deckx, S., Maurissen, K., & Probst, M. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2010.509458 · Cited by 123
Aerobic exercise and yoga improve neurocognitive function in women with early psychosis.
Lin, J., Chan, S. K., Lee, E. H., Chang, W. C., Tse, M., Su, W. W., Sham, P., Hui, C. L., Joe, G., Chan, C. L., et al. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2015.47 · Cited by 118
Bell, M., Fiszdon, J., Richardson, R., Lysaker, P., & Bryson, G. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.012 · Cited by 116
Yoga in schizophrenia: a systematic review of randomised controlled trials
Vancampfort, D., Vansteelandt, K., Scheewe, T., Probst, M., Knapen, J., De Herdt, A., & De Hert, M. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01865.x · Cited by 115
(2019) · doi:10.1007/978-3-662-59380-6 · Cited by 91
The development of modern yoga: A survey of the field
Newcombe, S. (2009) · Religion Compass · doi:10.1111/j.1749-8171.2009.00171.x · Cited by 89
Metacognitive training for psychosis (MCT): past, present, and future
Moritz, S., Menon, M., Balzan, R. P., & Woodward, T. S. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01394-9 · Cited by 87
Out of touch with reality? Social perception in first-episode schizophrenia
Ebisch, S. J. H., Salone, A., Ferri, F., De Berardis, D., Romani, G. L., Ferro, F. M., & Gallese, V. (2013) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nss012 · Cited by 77
Exploring changes in mindfulness and body appreciation during yoga participation
Cox, A. E., & McMahon, A. K. (2019) · Body Image · doi:10.1016/j.bodyim.2019.03.003 · Cited by 75
Sabe, M., Sentissi, O., & Kaiser, S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.030 · Cited by 72
The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis
Taylor, S. F., Grove, T. B., Ellingrod, V. L., & Tso, I. F. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz046 · Cited by 67
Mindfulness-Based Interventions for People with Schizophrenia: A Systematic Review and Meta-Analysis
Hodann-Caudevilla, R. M., Díaz-Silveira, C., Burgos-Julián, F. A., & Santed, M. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134690 · Cited by 60
Wie viele Menschen in Deutschland sind schwer psychisch krank?
Gühne, U., Becker, T., Salize, H.-J., & Riedel-Heller, S. (2015) · Psychiatrische Praxis · doi:10.1055/s-0035-1552715 · Cited by 58
Riehle, M., Böhl, M. C., Pillny, M., & Lincoln, T. M. (2020) · Clinical Psychology in Europe · doi:10.32872/cpe.v2i3.2899 · Cited by 51
Jacobsen, P., Hodkinson, K., Peters, E., & Chadwick, P. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.106 · Cited by 49
Böge, K., Karadza, A., Fuchs, L. M., Ehlen, F., Ta, T. M. T., Thomas, N., Bajbouj, M., & Hahn, E. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00600 · Cited by 46
Self-citationSchizophrenia in ICD-11: Comparison of ICD-10 and DSM-5
Valle, R. (2020) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2020.01.002 · Cited by 45
Böge, K., Hahne, I., Bergmann, N., Wingenfeld, K., Zierhut, M., Thomas, N., Ta, T. M. T., Bajbouj, M., & Hahn, E. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.008 · Cited by 44
Self-citationFaking it: social desirability response bias in self-report research
van de Mortel, T. (2008) · Australian Journal of Advanced Nursing · doi:10.37464/2008.254.1817 · Cited by 35
Development and Psychometric Evaluation of the Body Mindfulness Questionnaire
Burg, J. M., Probst, T., Heidenreich, T., & Michalak, J. (2017) · Mindfulness · doi:10.1007/s12671-016-0659-9 · Cited by 32
Govindaraj, R., Naik, S. S., Mehta, U. M., Sharma, M., Varambally, S., & Gangadhar, B. N. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102731 · Cited by 32
Schizophrenia in the flesh: Revisiting schizophrenia as a disorder of the bodily self
Park, S., & Baxter, T. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2021.12.031 · Cited by 30
Sabé, M., Kohler, R., Perez, N., Sauvain-Sabé, M., Sentissi, O., Jermann, F., Prada, P., Perroud, N., & Böge, K. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2023.12.011 · Cited by 29
Self-citationValidation of the German Version of the Southampton Mindfulness Questionnaire (SMQ)
Böge, K., Schaeuffele, C., Jacobsen, P., Chadwick, P., Ergen, E., Hahne, I., Bergmann, N., Boettcher, J., Wingenfeld, K., Bajbouj, M., et al. (2020) · Mindfulness · doi:10.1007/s12671-020-01447-x · Cited by 20
Self-citationCzobor, P., Sebe, B., Acsai, K., Barabássy, Á., Laszlovszky, I., Németh, G., Furukawa, T. A., & Leucht, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.816339 · Cited by 20
Kavak Budak, F., & Yilmaz, E. (2019) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2019.100949 · Cited by 19
Rochefort-Maranda, G. (2021) · Philosophical Studies · doi:10.1007/s11098-020-01424-z · Cited by 18
Die aktualisierte S3-Leitlinie Schizophrenie: Entwicklungsprozess und ausgewählte Empfehlungen
Hasan, A., Falkai, P., Lehmann, I., Janssen, B., Wobrock, T., Zielasek, J., & Gaebel, W. (2020) · Der Nervenarzt · doi:10.1007/s00115-019-00813-y · Cited by 18
Tonna, M., Lucarini, V., Borrelli, D. F., Parmigiani, S., & Marchesi, C. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac146 · Cited by 18
Schulze, T., Hahn, E., Hahne, I., Bergmann, N., Fuchs, L. M., Mähler, F., Zierhut, M. M., Ta, T. M. T., Pijnenborg, G. H. M., & Böge, K. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.715670 · Cited by 17
Self-citationGautam, S., Jain, A., Marwale, A., & Gautam, A. (2020) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_776_19 · Cited by 16
Moderne kognitive Verhaltenstherapie bei psychotischen Störungen
Pillny, M., & Lincoln, T. M. (2020) · Der Nervenarzt · doi:10.1007/s00115-019-00831-w · Cited by 15
Yin, J., Sun, Y., Zhu, Y., Alifujiang, H., Wang, Y., An, S., Huang, H., Fu, X., Deng, H., & Chen, Y. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.103959 · Cited by 15
Cognitive therapies for psychosis: Advances and challenges
Medalia, A., Beck, A. T., & Grant, P. M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.05.021 · Cited by 14
Töbelmann, L., Hahne, I., Schulze, T., Bergmann, N., Fuchs, L., Zierhut, M., Hahn, E., & Böge, K. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1086468 · Cited by 13
Self-citationYoga for Schizophrenia: a Review of Efficacy and Neurobiology
Dodell-Feder, D., Gates, A., Anthony, D., & Agarkar, S. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0125-6 · Cited by 7
Böge, K., Catena, D., & Hahn, E. (2022) · Verhaltenstherapie · doi:10.1159/000523900 · Cited by 3
Self-citation
Research works printed but not linked: 3
- 8. National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: treatment and management. NICE Clin Guideline 2014;178. [PubMed] [Google Scholar]
- 24. Galke M. Philosophie des Yoga. Das Gesetz des Einen-Verlag (Deutschland); 2024. [Google Scholar]
- 34. Böge K, Hahn E. Achtsamkeit bei psychotischen Störungen: Gruppentherapiemanual für die stationäre und ambulante Behandlung SENSE. Beltz; 2021. [Google Scholar]
Cited by
Hahne, I., Böge, K., Zierhut, M. M., Bergmann, N., Schulze, T., Hahn, E. W., Bajbouj, M., Calvano, C., Möritz, S., Gajic, V., et al. (2026) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2026.2627998
“A detailed description of the interventional study can be found in the original publication (Hahne et al., 2024).”
Self-citationBergmann, N., Conell, I., Hahne, I., Zierhut, M. M., Ta, T. M. T., Hahn, E., & Böge, K. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1748422 · Cited by 1
Self-citationTuncer, G. Z., & Kargın, K. (2026) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20260618-03
Metadata
- Authors
- Hahne, I., Zierhut, M., Bergmann, N., Hahn, E., Ta, T. M. T., Calvano, C., Bajbouj, M., & Böge, K.
- Affiliations
- Deutsches Zentrum für Psychische Gesundheit (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Corresponding author
- Hahne, Inge
- ORCID
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-11-16
- Volume
- 52
- Issue
- 1
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC12809801
- OpenAlex
- W4404460983
- Cited by
- 4
- References
- 66
- Citations by year
- 2026: 4
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Charité - Universitätsmedizin Berlin
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- yoga, schizophrenia spectrum disorders
- MeSH terms
- Adult, Feasibility Studies, Female, Humans, Inpatients, Male, Middle Aged, Patient Acceptance of Health Care, Psychotherapy, Group, Psychotic Disorders, Schizophrenia, Yoga, Single-Blind Method, Outcome Assessment, Health Care, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-26, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-26 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.